Questions of Value Raised over Amgen Purchase of Onyx as Stock Slips
Investors on Tuesday seemed a little less sure of biopharma behemoth Amgen’s decision to purchase cancer specialist Onyx for more than $10B over the weekend.
Archives for August 27, 2013
Waters Poring Over Candidates After CEO Announces Retirement Plan
Mass spec, chromatography and analytical tech firm Waters has started its search for a new CEO based on the assumption it will remain independent and keep the same growth strategy.
UPDATE
US FDA Worried as California Passes Biosimilar Use Bill
As California approves a Bill constraining biosimilar substitution, the US FDA says it is concerned at efforts to undermine strict federal legislation already in place.
Medimmune To Use Amplimmune's Plant in "Near Term" says AZ
Medimmune will use Aplimmune's biomanufacturing plant to further development of MAb and protein drug candidates says AstraZeneca.